Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia

Brian T. Brinkerhoff; David M. Poetker; Nicholas W. Choong

doi:10.1056/NEJMc1012774

Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia

Brian T. Brinkerhoff, David M. Poetker, Nicholas W. Choong

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	688-689
Number of pages	2
Journal	New England Journal of Medicine
Volume	364
Issue number	7
DOIs	https://doi.org/10.1056/NEJMc1012774
State	Published - Feb 17 2011
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc1012774

Cite this

@article{6501d1fcf2d14241af675cf249d8a36d,

title = "Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia",

author = "Brinkerhoff, {Brian T.} and Poetker, {David M.} and Choong, {Nicholas W.}",

year = "2011",

month = feb,

day = "17",

doi = "10.1056/NEJMc1012774",

language = "English (US)",

volume = "364",

pages = "688--689",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia

AU - Brinkerhoff, Brian T.

AU - Poetker, David M.

AU - Choong, Nicholas W.

PY - 2011/2/17

Y1 - 2011/2/17

UR - http://www.scopus.com/inward/record.url?scp=79951847934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951847934&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1012774

DO - 10.1056/NEJMc1012774

M3 - Letter

C2 - 21323562

AN - SCOPUS:79951847934

SN - 0028-4793

VL - 364

SP - 688

EP - 689

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this